Trials / Conditions / Triple-Negative Invasive Breast Carcinoma
Triple-Negative Invasive Breast Carcinoma
4 registered clinical trials studyying Triple-Negative Invasive Breast Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment for Triple Negative Breast Cancer Pat NCT02670109 | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Phase 2 |
| Unknown | CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor NCT02839954 | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | Phase 1 / Phase 2 |
| Unknown | Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor NCT02587689 | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | Phase 1 / Phase 2 |
| Completed | Olaparib and Radiotherapy in Inoperable Breast Cancer NCT02227082 | The Netherlands Cancer Institute | Phase 1 |